NEW YORK, Nov. 08, 2019 (GLOBE NEWSWIRE) — Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Covetrus, Inc. (NASDAQ:CVET) between February 8, 2019 and August 12, 2019, inclusive (the “Class Period”).
If you wish to serve as lead plaintiff, you must move the Court no later than November 29, 2019. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.
To join the class action, http://zhanginvestorlaw.com/join-action-form/?slug=covetrus-inc&id=2033 or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email [email protected] for information on the class action.
According to the lawsuit, throughout the Class Period, defendants and its senior executives presented false and misleading financial statements or omitted to disclose: (1) overstated Covetrus’ capabilities with regard to inventory management and supply chain services; (2) understated the costs of the integration of Henry Schein’s Animal Health Business and VFC, including the timing and nature of those costs; (3) understated Covetrus’ separation costs from Henry Schein; and (4) understated the impact on earnings from online competition and alternative distribution channels as well as the impact of the loss of a large customer in North America just prior to the Company’s separation from Henry Schein; and (5) as a result, Covetrus’ public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class has not been certified. You may retain counsel of your choice. You may take no action at this time and be an absent class member. Your ability to obtain a recovery is not dependent upon being a lead plaintiff.
Zhang Investor Law represents investors worldwide. Attorney Advertising. Prior results do not guarantee similar outcomes.
Zhang Investor Law P.C.
99 Wall Street, Suite 232
New York, New York 10005
tel: (800) 991-3756
Latest posts by GlobeNewswire (see all)
- WSG LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Wanda Sports Group Company Limited Investors of Important Deadline in Securities Class Action First Filed by the Firm – WSG - December 7, 2019
- Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial - December 7, 2019
- MERIT LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Merit Medical Systems, Inc. – MMSI - December 7, 2019